Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Argus Health
Federal Trade Commission
Baxter
McKinsey
Farmers Insurance
Fuji
Mallinckrodt
Daiichi Sankyo

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 021149

« Back to Dashboard

NDA 021149 describes OVIDREL, which is a drug marketed by Emd Serono and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the OVIDREL profile page.

The generic ingredient in OVIDREL is choriogonadotropin alfa. One supplier is listed for this compound. Additional details are available on the choriogonadotropin alfa profile page.
Summary for 021149
Tradename:OVIDREL
Applicant:Emd Serono
Ingredient:choriogonadotropin alfa
Patents:1
Pharmacology for NDA: 021149
Ingredient-typeGonadotropins
Suppliers and Packaging for NDA: 021149
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
OVIDREL choriogonadotropin alfa INJECTABLE;INJECTION 021149 NDA EMD Serono, Inc. 44087-1150 N 44087-1150-1
OVIDREL choriogonadotropin alfa INJECTABLE;SUBCUTANEOUS 021149 NDA EMD Serono, Inc. 44087-1150 N 44087-1150-1

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength0.25MG/VIAL
Approval Date:Sep 20, 2000TE:RLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;SUBCUTANEOUSStrengthEQ 0.25MG /0.5ML
Approval Date:Oct 6, 2003TE:RLD:Yes
Patent:➤ Sign UpPatent Expiration:Mar 16, 2021Product Flag?YSubstance Flag?Delist Request?

Expired US Patents for NDA 021149

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Emd Serono OVIDREL choriogonadotropin alfa INJECTABLE;INJECTION 021149-001 Sep 20, 2000 ➤ Sign Up ➤ Sign Up
Emd Serono OVIDREL choriogonadotropin alfa INJECTABLE;SUBCUTANEOUS 021149-002 Oct 6, 2003 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
McKinsey
QuintilesIMS
US Department of Justice
Farmers Insurance
Fuji
Moodys
Daiichi Sankyo
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.